TGA backs consumer adverts for ulipristal in Australia

Pharmacy News, 19 May, 2017

The TGA has agreed that consumer advertising should be allowed for the emergency contraceptive ulipristal.

This will help increase public awareness and access to ulipristal (branded EllaOne) and therefore reduce unplanned pregnancies, says the TGA.

 

 

Rescheduling of ulipristal acetate (EllaOne®) in Australia

SHine SA, October 2016

SHine SA and Family Planning Alliance Australia put in submissions to the TGA for the rescheduling of ulipristal acetate (EllaOne®), a new emergency contraceptive pill in Australia.

The rescheduling is from prescription-only to Schedule 3 (available in pharmacies with a pharmacy consultation). This has now been approved, to take place from February 2017.

This is an important access issue.

EllaOne® emergency contraception has also been added to the SHine SA formulary.

Access TGA information about ulipristal acetate (including links to the public submissions) here 

‘Five days after’ contraceptive pill launched by RU486 supplier

Sydney Morning Herald, April 27, 2016 – 12:01AM

An emergency contraceptive that works up to five days after unprotected sex has been launched by Australia’s sole supplier of medical abortion drug RU486.

The EllaOne pill, from non-profit pharmaceutical group MS Health, is available from Wednesday.

Read more here